Skip to content
Author

Aliso Viejo medical device maker Sequent Medical Inc. said it has raised $26 million in its third round of venture capital equity financing.

Delphi Ventures led the round that included existing investors Versant Ventures, US Venture Partners and Domain Associates. James Bochnowski of Delphi Ventures will join Sequent’s board of directors.

Sequent is developing catheter-based technologies to treat neurovascular problems. Its proprietary MicroBraid creates a low-porous WEB within an aneurysm to help healing, the company said. The device is already available in a few markets in Europe but not in the United States.

Sequent President and CEO Tom Wilder said, “We will utilize these funds to support our clinical, commercial and technology development programs, including our initial WEB Aneurysm Embolization System product line.”

In addition to its Orange County headquarters, Sequent has an office in Bonn, Germany.

Other business stories…